VitaDAO, a decentralized autonomous organization focused on raising funds for research on extending human life, raised $4.1M in funding.
Backers included Pfizer Ventures, Shine Capital, L1 Digital; decentralised science and web3 organisations Beaker DAO and Spaceship DAO; and longevity enthusiasts including Balaji Srinivasan (former CTO of Coinbase and General Partner at a16z) and Joe Betts-LaCroix (Retro Biosciences) and many others.
The DAO intends to use the capital to fund further longevity research projects and precede the spinout of its first biotech startups, scheduled in the first quarter of 2023, as well as further investment in commercialization and licensing of its IP-NFT assets through its partnership with Molecule DAO.
Founded by Tyler Golato, VitaDAO is a global community for the acceleration of research and development (R&D) in longevity science and the extension of human health- and life-span. With a community of over 9000 enthusiasts, researchers, and contributors, the organization in 2022 deployed over $3.5M USD in 15+ projects researching the diseases of ageing, with a focus on cellular biology and the repair of damage associated with the hallmarks of ageing.
FinSMEs
06/02/2023